Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

What symbol and exchange does Harrow shares trade?

Harrow trades on the NASDAQ stock market under the symbol HROW.

What is Harrow stock price doing today?

As of October 30, 2026, HROW stock price declined to $28.24 with 310,062 million shares trading.

What is Harrow's Beta?

HROW has a beta of 1.98, meaning it tends to be more sensitive to market movements. HROW has a correlation of 0.12 to the broad based SPY ETF.

How much is Harrow worth?

HROW has a market cap of $1.06 billion. This is considered a Small Cap stock.

How much money does Harrow make?

Last quarter Harrow reported $71 million in Revenue and -$.46 earnings per share. This beat revenue expectation by $160,904 and missed earnings estimates by -$.22.

What is the highest and lowest price Harrow traded in the last 3 year period?

In the last 3 years, HROW traded as high as $59.23 and as low as $7.60.

What are the top ETFs holding Harrow?

The top ETF exchange traded funds that HROW belongs to (by Net Assets): VTI, IWM, VXF, IWO, FESM.

Is Harrow (HROW) a good investment?

HROW has underperformed the market in the last year with a return of -24.8%, while the SPY ETF gained +12.3%. In the last 3 month period, HROW fell short of the market, returning -27.5%, while SPY returned +2.1%. However, in the most recent 2 weeks HROW has outperformed the stock market by returning +3.5%, while SPY returned -1.0%.

What are the support and resistance levels for Harrow (HROW)?

HROW support price is $29.01 and resistance is $30.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HROW shares will trade within this expected range on the day.